We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
+1.37%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$11.4B
AUM Growth
+$504M
(+4.6%)
Cap. Flow
+$402M
Cap. Flow
% of AUM
3.53%
Top 10 Holdings %
Top 10 Hldgs %
17.81%
Holding
2,458
New
259
Increased
1,134
Reduced
877
Closed
119
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$23.1M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$23.1M |
| 3 |
First Trust Enhanced Short Maturity ETF
FTSM
|
+$19M |
| 4 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$15.7M |
| 5 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$15.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$28M |
| 2 |
First Trust Smith Unconstrained Bond ETF
UCON
|
+$23.9M |
| 3 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$18.3M |
| 4 |
First Trust Smith Opportunistic Fixed Income ETF
FIXD
|
+$9.64M |
| 5 |
Vanguard Total International Stock ETF
VXUS
|
+$8.31M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.41% |
| 2 | Financials | 4.96% |
| 3 | Healthcare | 3.93% |
| 4 | Consumer Discretionary | 3.62% |
| 5 | Industrials | 3.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Vanguard S&P Small-Cap 600 ETF
VIOO
$4.35B
| $1.26M | 0.01% |
17,724
-5,136
| -22% | -$363K |
|
952
Madrigal Pharmaceuticals
MDGL
$11.7B
| $1.26M | 0.01% |
14,600
-100
| -0.7% | -$9.38K |
|
953
iShares Core US REIT ETF
USRT
$4.63B
| $1.26M | 0.01% |
22,643
-6,094
| -21% | -$328K |
|
954
JD.com
JD
$39.6B
| $1.26M | 0.01% |
44,568
-6,859
| -13% | -$207K |
|
955
Estee Lauder
EL
$31.6B
| $1.25M | 0.01% |
6,301
+642
| +11% | +$123K |
|
956
UGI
UGI
$7.56B
| $1.25M | 0.01% |
24,878
+16,759
| +206% | +$837K |
|
957
Vertex Pharmaceuticals
VRTX
$131B
| $1.25M | 0.01% |
7,378
-20
| -0.3% | -$3.54K |
|
958
Lamb Weston
LW
$7.39B
| $1.25M | 0.01% |
17,177
+473
| +3% | +$32.4K |
|
959
Invesco S&P 500 Equal Weight Financials ETF
RSPF
$313M
| $1.25M | 0.01% |
28,578
-5,121
| -15% | -$221K |
|
|
PBCT
960
DELISTED
People's United Financial Inc
PBCT
| $1.24M | 0.01% |
79,579
-49,696
| -38% | -$777K |
|
|
HIE
961
DELISTED
Miller/Howard High Income Equity Fund
HIE
| $1.24M | 0.01% |
114,183
-1,703
| -1% | -$18.8K |
|
962
Eastman Chemical
EMN
$8.43B
| $1.24M | 0.01% |
16,816
-286
| -2% | -$20.5K |
|
963
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.59B
| $1.24M | 0.01% |
61,982
-1,536
| -2% | -$30K |
|
964
Invesco China Technology ETF
CQQQ
$3.19B
| $1.24M | 0.01% |
27,011
+3,636
| +16% | +$165K |
|
965
J.M. Smucker
SJM
$12.9B
| $1.24M | 0.01% |
11,233
-1,198
| -10% | -$134K |
|
966
KeyCorp
KEY
$24.6B
| $1.24M | 0.01% |
69,252
+18,948
| +38% | +$328K |
|
967
Uber
UBER
$155B
| $1.23M | 0.01% |
+40,417
| New | +$1.52M |
|
968
BCE
BCE
$21.7B
| $1.23M | 0.01% |
25,345
+1,853
| +8% | +$86.7K |
|
969
First Trust Nasdaq Bank ETF
FTXO
$321M
| $1.22M | 0.01% |
47,838
-2,813
| -6% | -$70.5K |
|
970
Kemper
KMPR
$1.59B
| $1.22M | 0.01% |
15,700
| – | – |
|
|
DWTR
971
DELISTED
Invesco DWA Tactical Sector Rotation ETF
DWTR
| $1.22M | 0.01% |
38,937
+4,775
| +14% | +$153K |
|
972
State Street SPDR S&P Global Infrastructure ETF
GII
$930M
| $1.22M | 0.01% |
22,817
+365
| +2% | +$19.2K |
|
973
Schwab International Small-Cap Equity ETF
SCHC
$5.69B
| $1.21M | 0.01% |
38,170
-6,808
| -15% | -$217K |
|
|
PXD
974
DELISTED
Pioneer Natural Resource Co.
PXD
| $1.21M | 0.01% |
9,623
+1,913
| +25% | +$253K |
|
975
Align Technology
ALGN
$12.5B
| $1.21M | 0.01% |
6,670
-519
| -7% | -$108K |
|
Similar funds
LP
HF
RIM
Cambridge Investment Research Advisors's Q3 2019 Portfolio in Review
As of Q3 2019, Cambridge Investment Research Advisors held 2,458 positions worth $11.4B, up 4.6% from $10.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Cambridge Investment Research Advisors deployed $402M of net new capital in Q3 2019, opening 259 new positions and adding to 1,134 existing holdings. Its largest new stake was Invesco S&P Ultra Dividend Revenue ETF: 309,094 shares worth $11.7M.
By sector, the portfolio is most concentrated in Technology at 6.4% of assets, up from 6.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Vanguard Short-Term Treasury ETF, an estimated $28M trimmed.
- Cambridge Investment Research Advisors's largest Q3 2019 buy was Invesco S&P Ultra Dividend Revenue ETF: 309,094 shares worth $11.7M.
- Cambridge Investment Research Advisors added most to iShares 7-10 Year Treasury Bond ETF in Q3 2019, an estimated $23.1M increase.
- Cambridge Investment Research Advisors's biggest Q3 2019 reduction was Vanguard Short-Term Treasury ETF, cutting an estimated $28M.
- Cambridge Investment Research Advisors fully exited DXC Technology in Q3 2019, selling an estimated $3.71M.
- Cambridge Investment Research Advisors's ten largest holdings make up 18% of its $11.4B portfolio in Q3 2019.
- Cambridge Investment Research Advisors opened 259 new positions and closed 119 in Q3 2019.
- Cambridge Investment Research Advisors's portfolio value rose 4.6% quarter-over-quarter to $11.4B.
Based on Cambridge Investment Research Advisors's 13F filing for Q3 2019, filed 28 Oct 2019.